February 01, 2015 6:28 PM ET


Company Overview of AGY Therapeutics, Inc.

Company Overview

AGY Therapeutics Inc., a biotechnology company, engages in the discovery, development, and commercialization of central nervous system (CNS) therapeutics to cure neurological diseases and disorders. It engages in developing treatments for neurodegenerative diseases, acute neuroprotection, CNS injuries, stroke, and cognitive diseases and schizophrenia. The company also develops solutions for enhancement and functional recovery after stroke; and oncology antibody program that focuses on the identification of proteins expressed by brain tumors and on the development of therapeutics for the treatment of glioblastoma multiforme. In addition, it engages in identifying and validating targets for th...

270 East Grand Avenue

South San Francisco, CA 94080

United States

Founded in 1998





Key Executives for AGY Therapeutics, Inc.

Chief Executive Officer
Age: 59
Age: 66
Vice President of Finance and Treasurer
Chief Operating Officer
Age: 57
Senior Vice President of Drug Discovery and Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Hisun Pharmaceuticals USA Inc. United States
Pinnacle Pharmaceuticals, Inc. United States
Infusion Specialties Inc. United States
Mirror Pharmaceuticals LLC United States
PharmaMar USA, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGY Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.